News PREDILIFE

Stocks

ALPRE

FR0010169920

Biotechnology & Medical Research

Market Closed - Euronext Paris 12:55:00 2026-10-30 EDT			5-day change	1st Jan Change
0.8500 ^EUR	-.--%		-15.84%	-71.76%

06-28	Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-09	Intégrance Launches Preventive Health Program for Employees

All News

Mentions Relevance

06-28	Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-09	Intégrance Launches Preventive Health Program for Employees
25-10-24	PREDILIFE : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2025	PU
25-10-09	PREDILIFE : RESULTATS SEMESTRIELS 2025	PU
25-10-09	Predilife S.A. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-07-02	Predilife S.A. announced a financing transaction	CI
25-06-05	Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-04-09	Edil San Felice Bags EUR16 Million Maintenance Works Contract in Italy	MT
24-05-29	Predilife : PREDILIFE STRENGTHENS ITS ASSETS WITH THE ISSUANCE OF A PATENT FOR ITS AI METHOD	AT
24-05-01	Predilife : IN EXTENSO FINANCE UPDATES COVERAGE ON PREDILIFE STOCK; TARGET PRICE OF EUR 25.07 REPRESENTS +391% POTENTIAL UPSIDE	AT
24-04-25	Predilife : Valuation of MammoRisk(R) software	AT
24-04-23	Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
23-09-04	Predilife: a project accredited by Finance Innovation
23-07-14	Predilife S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-04-27	Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-04-12	Predilife: predictive assessment contract with Colas
22-10-28	Predilife S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	CI
22-04-25	Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
21-12-20	Predilife Taps Eurofins to Conduct Genetic Testing of Saliva Samples	MT
21-09-28	Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	CI
19-05-06	Predilife S.A. and Institut Curie Announce Partnership Covering Genetic Analyses for Mammorisk, the Next-Generation Test Predicting the Risk of Breast Cancer	CI
19-05-06	PrediLife : and the Institut Curie Announce a Partnership Covering Genetic Analyses for MammoRisk®, the Next-Generation Test Predicting the Risk of Breast Cancer	BU
18-12-18	Predilife S.A. has completed an IPO in the amount of €3.591232 million.	CI
18-12-04	Predilife S.A. has filed an IPO in the amount of €7.006296 million.	CI